In the study of congenital hyperinsulinism now enrolling phase III sunRIZE trial

sunrize logo

Treatment Of Severe Refractory Hypoglycemia Due To Malignant Insulinoma With A Novel Anti-Insulin Receptor Antibody

Back to Careers